LLY FY 2014 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

FY 2014 Earnings

Reported February 19, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$19.6B	—	$23.1B	—	-15.1%
Op. Income	$3.3B	—	$5.5B	—	-40.0%
Gross Margin	74.9%	—	78.8%	—	-3.9pp
Net Margin	12.2%	—	20.3%	—	-8.1pp
EPS (Diluted)	$2.15	—	$4.19	—	-48.7%
Free Cash Flow	$2.9B	—	$4.6B	—	-37.7%

Revenue Flow

Item	Amount
REVENUE	$19.6B
Cost of Revenue	$4.9B
GROSS PROFIT	$14.7B
R&D Expenses	$4.7B
Selling & Marketing	$0
General & Administrative	$6.6B
SG&A Expenses	$6.6B
Other Expenses	$0
Operating Expenses	$11.4B
Cost & Expenses	$16.3B
OPERATING INCOME	$3.3B
Interest Income	$121M
Interest Expense	$149M
Other Income/Expenses	-$328M
INCOME BEFORE TAX	$3.0B
Income Tax Expense	$610M
Net Income from Continuing Ops	$2.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.4B
D&A	$1.4B
EBIT	$3.1B
EBITDA	$4.5B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$19.6B
Cost of Revenue	$4.9B
GROSS PROFIT	$14.7B
R&D Expenses	$4.7B
Selling & Marketing	$0
General & Administrative	$6.6B
SG&A Expenses	$6.6B
Other Expenses	$0
Operating Expenses	$11.4B
Cost & Expenses	$16.3B
OPERATING INCOME	$3.3B
Interest Income	$121M
Interest Expense	$149M
Other Income/Expenses	-$328M
INCOME BEFORE TAX	$3.0B
Income Tax Expense	$610M
Net Income from Continuing Ops	$2.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.4B
D&A	$1.4B
EBIT	$3.1B
EBITDA	$4.5B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$2.4B
Depreciation & Amortization	$1.4B
Stock-Based Compensation	$156M
Deferred Income Tax	$37M
Other Non-Cash Items	$13M
Change in Working Capital	$484M
OPERATING CASH FLOW	$4.5B
Capital Expenditure	-$1.6B
Acquisitions (Net)	-$551M
Purchases of Investments	-$11.4B
Sales/Maturities of Investments	$15.1B
Other Investing Activities	-$5.4B
NET CASH FROM INVESTING	-$3.9B
Net Debt Issuance	$2.6B
Common Stock Repurchased	-$800M
Common Dividends Paid	-$2.1B
Other Financing Activities	$96M
NET CASH FROM FINANCING	-$166M
FREE CASH FLOW	$2.9B
Net Change in Cash	$41M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.9B
Short-Term Investments	$955M
Net Receivables	$3.8B
Inventory	$2.7B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$11.9B
PP&E (Net)	$8.0B
Goodwill	$1.8B
Intangible Assets	$2.9B
Long-Term Investments	$4.6B
Tax Assets	$1.5B
Other Non-Current Assets	$5.7B
TOTAL NON-CURRENT ASSETS	$24.4B
TOTAL ASSETS	$36.3B
Account Payables	$1.1B
Short-Term Debt	$2.7B
Deferred Revenue	$0
Other Current Liabilities	$3.8B
TOTAL CURRENT LIABILITIES	$11.2B
Long-Term Debt	$5.3B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$5.8B
TOTAL NON-CURRENT LIABILITIES	$11.2B
TOTAL LIABILITIES	$20.9B
Common Stock	$695M
Additional Paid-In Capital	$5.3B
Retained Earnings	$16.5B
Treasury Stock	-$91M
Accum. Other Comp. Income	-$4.0B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$15.4B
Minority Interest	$15M
TOTAL EQUITY	$15.4B
TOTAL LIABILITIES & EQUITY	$36.3B
Total Debt	$8.1B
Net Debt	$4.2B